Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) — Form 8-K: Current report
About this filing
Neurocrine Biosciences, Inc. (NBIX) filed an 8-K on Sep 28, 2026 reporting an executive or director change or pay arrangement (Item 5.02).
Key facts
- Item 5.02 · Executive or director change or pay arrangement
More NBIX filings
- 144
Filed Oct 30, 2026
- SC 13G
Filed Oct 30, 2026
- SC 13G/A
Filed Oct 15, 2026
- 3
Filed Oct 7, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 15, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.